Du är här


Gemalto: Gemalto M2M Solution Enables Next-Generation mHealth

Smart pill dispenser with wireless connectivity improves well-being,
independence and peace of mind for patients, relatives and caregivers

Amsterdam, May 20, 2014
- Gemalto (Euronext NL 0000400653 GTO), the world leader in digital security,
announces its Cinterion®M2M technology is providing wireless cellular
connectivity for the next-generation ofpill dispensers. Developed by
MedMinder and wirelessly enabled by Gemalto, the advancedmHealthdevice for
convenient patient use tracks medication intake, sends medical alerts, orders
refills and improves prescription compliance. The new, innovative dispenser
enhances communication between patients and caregivers, improving the overall
well-being, independence and peace of mind for patients.

MedMinder's smart pill dispensers, equipped with Gemalto's advanced M2M
module, monitor medication usage and send data from the pill box over
wireless networks to a central server. Physicians and caregivers can log on
to MedMinder's secure web interface to observe medication adherence and
manage changes when necessary. Gemalto's 20 years' experience in security
combined with its M2M technology ensures this personal information is
accessed only by authorized individuals. Continued success of the mHealth
industry relies on secure data protection, in which Gemalto is playing a key

The solution provides an audio alarm to alert the patient when medication
should be taken. Caregivers also receive alerts if scheduled doses are missed
giving caregivers the ability to offer real-time support for an enhanced
level of medical care. The patient can chose their preferred method of
communication as the connectivity enables thepill dispenserto send reminders
via text message, email or a phone call. In addition, MedMinder Medication
Dispenser hasMedical Alertembedded for two way voice channel with the
patient's monitoring center in case of an emergency.

"The Gemalto M2M solution allows for secure connectivity that provides 24/7
automated communication between the pill box, patient, doctor and medical
alert monitoring center depending on the urgency of the situation"
said Eran Shavelsky, CEO of MedMinder."The technology also offers flexibility
and cost-effectiveness for our devices
with the option to add new features and expand capabilities in the future
without having to redesign the device."

"The Gemalto Cinterion PHS8 module is the slimmest M2M module on the market,
and ideally suited to MedMinder's compact solution,"
said Paul Kobos, Head of M2M Sales for Gemalto North America."With an aging
population and growing need for chronic care management,
Gemalto M2M technology truly impacts patients' day-to-day care while
protecting data and can be seamlessly integrated into healthcare IT systems."

About Gemalto

Gemalto (Euronext NL0000400653 GTO) is the world leader indigital securitywith
2013 annual revenues of €2.4 billion and more than 12,000 employees operating
out of 85 offices and 25 research and software development centers, located
in 44 countries.

We are at the heart of the rapidly evolving digital society. Billions of
people worldwide increasingly want the freedom to communicate, travel, shop,
bank, entertain and work - anytime, everywhere - in ways that are enjoyable
and safe. Gemalto delivers on their expanding needs for personal mobile
services, payment security, authenticated cloud access, identity and privacy
protection, eHealthcare and eGovernment efficiency, convenient ticketing and
dependable machine-to-machine (M2M) applications. We develop secure embedded
software and secure products which we design and personalize. Our platforms
and services manage these products, the confidential data they contain and
the trusted end-user services made possible.

Our innovations enable our clients to offer trusted and convenient digital
services to billions of individuals. Gemalto thrives with the growing number
of people using its solutions to interact with the digital and wireless

For more information
visitwww.gemalto.com,www.justaskgemalto.com,blog.gemalto.com, or
follow@gemaltoon Twitter.

Gemalto Media Contacts:

|Peggy Edoire Nicole Williams |
|Europe, Middle East&Africa |
|+33 4 42 36 45 40 North America |
|peggy.edoire@gemalto.com +1 512 758 8921 |
| nicole.williams@gemalto.com |
|Pierre Lelievre Ernesto Haikewitsch |
| |
|Asia Pacific Latin America |
|+65 6317 3802 +55 11 5105 9220 |
|pierre.lelievre@gemalto.com ernesto.haikewitsch@gemalto.com |
About MedMinder

MedMinder provides technologies to enable seniors, the chronically ill, and
those with disabilities to maintain their independence and avoid long-term
care facilities and hospitalization. MedMinder medication management system
includes cellular pill dispenser that records user activity the reports to
the MedMinder back end system. Accordingly, MedMinder provides reminders to
the users to take their pills on time and informs families and care managers
if dosages are missed. MedMinder technology is proven to simplify medication
management and improve medication adherence. For more information,

Press release (PDF)
Gemalto M2M Solution Enables Next-Generation mHealth


This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Gemalto via Globenewswire


Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.